Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke.

Brain research | 2013

Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) is a well-known pro-inflammatory chemokine and its role in ischemic stroke remains controversial. We examined the significance of RANTES in ischemic stroke and aimed to elucidate the direct effect of RANTES on neurons. Plasma concentrations of major C-C chemokines, including RANTES, and neurotrophic factors were examined in 171 ischemic stroke patients and age- and gender- matched healthy subjects. Plasma concentrations of RANTES at day 0 after onset were significantly elevated in stroke patients, compared with controls, and were highly correlated with those of BDNF, EGF, and VEGF. In a mouse middle cerebral artery occlusion model (MCAO), plasma RANTES was significantly elevated and the expression of RANTES was markedly upregulated in neurons particularly in peri-infarct areas. The expression of CCR3 and CCR5, receptors for RANTES, was also induced in neurons, while another receptor, CCR1, was observed in vascular cells, in peri-infarct areas after MCAO. We examined the effects of RANTES on differentiated PC12 cells, a model of neuronal cells. Treatment with RANTES induced the activation of Akt and Erk1/2, and attenuated the cleavage of caspase-3 in the cells. RANTES increased the expression of BDNF, EGF, and VEGF in the cells. Moreover, RANTES maintained the number of cells under serum free conditions. The RANTES-mediated upregulation of neurotrophic factors and cell survival were significantly attenuated by the inhibition of Akt or Erk1/2. Taken together, RANTES is an interesting chemokine that is produced from neurons after ischemic stroke and has the potential to protect neurons directly or indirectly through the production of neurotrophic factors in peri-infarct areas.

Pubmed ID: 23602964 RIS Download

Mesh terms: Aged | Animals | Brain | Brain Ischemia | Brain-Derived Neurotrophic Factor | Case-Control Studies | Caspase 3 | Cell Differentiation | Cell Survival | Chemokine CCL5 | Chemokines, CC | Disease Models, Animal | Dose-Response Relationship, Drug | Enzyme Inhibitors | Female | Gene Expression Regulation | Humans | Male | Mice | Middle Aged | Nerve Growth Factor | Nerve Tissue Proteins | Neurons | Neuroprotective Agents | PC12 Cells | Rats | Signal Transduction | Stroke | Time Factors

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal antibody targets Iba1

View all literature mentions

p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb antibody (antibody)

RRID:AB_390779

This monoclonal antibody targets p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb

View all literature mentions

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) antibody (antibody)

RRID:AB_2315112

This monoclonal antibody targets p44 / 42 MAPK, phospho (Thr202 / Tyr204)

View all literature mentions

Anti-Olig-2 Antibody (antibody)

RRID:AB_570666

This polyclonal antibody targets Olig-2

View all literature mentions

Anti-Calretinin antibody (antibody)

RRID:AB_2068506

This polyclonal antibody targets Calretinin

View all literature mentions

Monoclonal Anti-Calbindin-D-28K antibody produced in mouse (antibody)

RRID:AB_476894

This monoclonal antibody targets Calbindin-D-28K antibody produced in mouse

View all literature mentions

Phospho-GSK-3 (Ser9) Antibody (antibody)

RRID:AB_331405

This polyclonal antibody targets Phospho-GSK-3 (Ser9)

View all literature mentions

Anti-Synuclein, alpha, clone 7B12.2 antibody (antibody)

RRID:AB_95210

This monoclonal antibody targets Synuclein alpha clone 7B12.2

View all literature mentions

Anti-Glial Fibrillary Acidic Protein (GFAP) antibody (antibody)

RRID:AB_2109645

This polyclonal antibody targets Glial Fibrillary Acidic Protein (GFAP)

View all literature mentions

GSK-3beta (27C10) Rabbit mAb antibody (antibody)

RRID:AB_490890

This monoclonal antibody targets GSK-3beta (27C10) Rabbit mAb

View all literature mentions

Anti-NeuN antibody (antibody)

RRID:AB_2298772

This monoclonal antibody targets NeuN

View all literature mentions

Akt (pan) (C67E7) Rabbit mAb antibody (antibody)

RRID:AB_915783

This monoclonal antibody targets Akt (pan) (C67E7) Rabbit mAb

View all literature mentions

Anti-CNPase, clone 11-5B antibody (antibody)

RRID:AB_2082608

This monoclonal antibody targets Cnp

View all literature mentions